Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)

Jørn Herrstedt, J. Rolski, M. Guckert, I. Camlett, M. W. Russo, J. Strausz, Z. Aziz

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2008
StatusUdgivet - 2008
BegivenhedAmerican Society of Clinical Oncology - Chicago, USA
Varighed: 30. maj 20083. jun. 2008
Konferencens nummer: 44

Konference

KonferenceAmerican Society of Clinical Oncology
Nummer44
LandUSA
ByChicago
Periode30/05/200803/06/2008

Citationsformater